After initially rejecting the brain-chip company's application, the US Food and Drugs Authority (FDA) has now given the green light for Neuralink to carry out in-human studies.

Funded by Elon Musk, Neuralink is a neurotechnology company that aims to create cranial computers to treat diseases and merge new advanced software abilities with the human brain. 

In addition to potentially treating brain diseases such as epilepsy and Parkinson’s, the implanted device would also act as a sort of 'digital layer' that merges human grey matter with advanced technological tools.

The company revealed the news of its FDA approval on Twitter, the social media platform also owned by billionaire Elon Musk. In the same post, Neuralink also said it does not have immediate plans to start recruiting participants.